The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Peter J. Barnes

National Heart and Lung Institute

Imperial College

London

United Kingdom

[email]@imperial.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • National Heart and Lung Institute, Imperial College, London, United Kingdom. 2003 - 2012
  • Imperial College, London, UK. 2010

References

  1. Severe asthma: advances in current management and future therapy. Barnes, P.J. J. Allergy Clin. Immunol. (2012) [Pubmed]
  2. Osteoprotegerin in Sputum Is a Potential Biomarker in COPD. To, M., Ito, K., Ausin, P.M., Kharitonov, S.A., Barnes, P.J. Chest (2011) [Pubmed]
  3. Nortriptyline Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-{delta}. Mercado, N., To, Y., Ito, K., Barnes, P.J. J. Pharmacol. Exp. Ther. (2011) [Pubmed]
  4. Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design. Barnes, P.J., Pocock, S.J., Magnussen, H., Iqbal, A., Kramer, B., Higgins, M., Lawrence, D. Pulm. Pharmacol. Ther (2010) [Pubmed]
  5. Mechanisms and resistance in glucocorticoid control of inflammation. Barnes, P.J. J. Steroid Biochem. Mol. Biol. (2010) [Pubmed]
  6. Chronic obstructive pulmonary disease: effects beyond the lungs. Barnes, P.J. PLoS Med. (2010) [Pubmed]
  7. Role of HDAC2 in the pathophysiology of COPD. Barnes, P.J. Annu. Rev. Physiol. (2009) [Pubmed]
  8. Glucocorticoid resistance in inflammatory diseases. Barnes, P.J., Adcock, I.M. Lancet (2009) [Pubmed]
  9. Histone deacetylase-2 and airway disease. Barnes, P.J. Ther. Adv. Respir. Dis (2009) [Pubmed]
  10. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Barnes, P.J. Proc. Am. Thorac. Soc (2009) [Pubmed]
  11. Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Barnes, P.J. Clin. Exp. Allergy (2009) [Pubmed]
  12. The cytokine network in chronic obstructive pulmonary disease. Barnes, P.J. Am. J. Respir. Cell Mol. Biol. (2009) [Pubmed]
  13. Systemic manifestations and comorbidities of COPD. Barnes, P.J., Celli, B.R. Eur. Respir. J. (2009) [Pubmed]
  14. Role of GATA-3 in allergic diseases. Barnes, P.J. Curr. Mol. Med. (2008) [Pubmed]
  15. Immunology of asthma and chronic obstructive pulmonary disease. Barnes, P.J. Nat. Rev. Immunol. (2008) [Pubmed]
  16. A blood test for lung fibrosis. Barnes, P.J. PLoS Med. (2008) [Pubmed]
  17. Frontrunners in novel pharmacotherapy of COPD. Barnes, P.J. Curr. Opin. Pharmacol (2008) [Pubmed]
  18. The cytokine network in asthma and chronic obstructive pulmonary disease. Barnes, P.J. J. Clin. Invest. (2008) [Pubmed]
  19. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Barnes, P.J. Proc. Am. Thorac. Soc (2008) [Pubmed]
  20. Emerging pharmacotherapies for COPD. Barnes, P.J. Chest (2008) [Pubmed]
  21. The problem of cough and development of novel antitussives. Barnes, P.J. Pulm. Pharmacol. Ther (2007) [Pubmed]
  22. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. Barnes, P.J. BMJ (2007) [Pubmed]
  23. Scientific rationale for using a single inhaler for asthma control. Barnes, P.J. Eur. Respir. J. (2007) [Pubmed]
  24. New molecular targets for the treatment of neutrophilic diseases. Barnes, P.J. J. Allergy Clin. Immunol. (2007) [Pubmed]
  25. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. Barnes, P.J. PLoS Med. (2007) [Pubmed]
  26. Novel signal transduction modulators for the treatment of airway diseases. Barnes, P.J. Pharmacol. Ther. (2006) [Pubmed]
  27. Drugs for asthma. Barnes, P.J. Br. J. Pharmacol. (2006) [Pubmed]
  28. Reduced histone deacetylase in COPD: clinical implications. Barnes, P.J. Chest (2006) [Pubmed]
  29. Corticosteroid effects on cell signalling. Barnes, P.J. Eur. Respir. J. (2006) [Pubmed]
  30. Pulmonary biomarkers in chronic obstructive pulmonary disease. Barnes, P.J., Chowdhury, B., Kharitonov, S.A., Magnussen, H., Page, C.P., Postma, D., Saetta, M. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  31. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Barnes, P.J. Br. J. Pharmacol. (2006) [Pubmed]
  32. Receptor heterodimerization: a new level of cross-talk. Barnes, P.J. J. Clin. Invest. (2006) [Pubmed]
  33. New therapies for asthma. Barnes, P.J. Trends. Mol. Med (2006) [Pubmed]
  34. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Barnes, P.J., Adcock, I.M., Ito, K. Eur. Respir. J. (2005) [Pubmed]
  35. COPD: current therapeutic interventions and future approaches. Barnes, P.J., Stockley, R.A. Eur. Respir. J. (2005) [Pubmed]
  36. Will it be steroids for ever?. Barnes, P.J. Clin. Exp. Allergy (2005) [Pubmed]
  37. Theophylline in chronic obstructive pulmonary disease: new horizons. Barnes, P.J. Proc. Am. Thorac. Soc (2005) [Pubmed]
  38. Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment. Barnes, P.J. Expert Opin. Ther. Targets (2005) [Pubmed]
  39. Emerging targets for COPD therapy. Barnes, P.J. Curr. Drug. Targets. Inflamm. Allergy (2005) [Pubmed]
  40. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Barnes, P.J., Ito, K., Adcock, I.M. Lancet (2004) [Pubmed]
  41. Asthma guidelines: recommendations versus reality. Barnes, P.J. Respir. Med (2004) [Pubmed]
  42. COPD: is there light at the end of the tunnel?. Barnes, P.J. Curr. Opin. Pharmacol (2004) [Pubmed]
  43. COPD--a neglected disease. Barnes, P.J., Kleinert, S. Lancet (2004) [Pubmed]
  44. Prospects for new drugs for chronic obstructive pulmonary disease. Barnes, P.J., Hansel, T.T. Lancet (2004) [Pubmed]
  45. New drugs for asthma. Barnes, P.J. Nat. Rev. Drug. Discov (2004) [Pubmed]
  46. The size of the problem of managing asthma. Barnes, P.J. Respir. Med (2004) [Pubmed]
  47. Characterization of T lymphocytes in chronic obstructive pulmonary disease. Barnes, P.J., Cosio, M.G. PLoS Med. (2004) [Pubmed]
  48. Alveolar macrophages in chronic obstructive pulmonary disease (COPD). Barnes, P.J. Cell. Mol. Biol. (Noisy-le-grand) (2004) [Pubmed]
  49. Mediators of chronic obstructive pulmonary disease. Barnes, P.J. Pharmacol. Rev. (2004) [Pubmed]
  50. Corticosteroid resistance in airway disease. Barnes, P.J. Proc. Am. Thorac. Soc (2004) [Pubmed]
  51. Distribution of receptor targets in the lung. Barnes, P.J. Proc. Am. Thorac. Soc (2004) [Pubmed]
  52. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Barnes, P.J., Shapiro, S.D., Pauwels, R.A. Eur. Respir. J. (2003) [Pubmed]
  53. New treatments for chronic obstructive pulmonary disease. Barnes, P.J. Ann. Ist. Super. Sanita (2003) [Pubmed]
 
WikiGenes - Universities